Moderna Inc. stock rises Thursday, outperforms market

© Terrence Horan


Shares of Moderna Inc. MRNA advanced 5.09% to $144.00 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.84% to 12,764.75 and the Dow Jones Industrial Average DJIA rising 0.49% to 30,303.37. The stock’s rise snapped a three-day losing streak. Moderna Inc. closed $34.50 short of its 52-week high ($178.50), which the company achieved on December 1st.

The stock outperformed some of its competitors Thursday, as AbbVie Inc. ABBV rose 0.24% to $104.89, Amgen Inc. AMGN rose 1.23% to $231.24, and AstraZeneca PLC ADR AZN fell 0.27% to $50.79. Trading volume (29.9 M) eclipsed its 50-day average volume of 20.3 M.

Editor’s Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

Continue Reading